You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ELVN Sale Disclosure
Orbimed Advisors Llc · SEC Form 4 · Filed Jun 24, 2026
Sale
Calculated transaction value
$35.72M
Orbimed Advisors Llc 10% owner
ELVN
Enliven Therapeutics
ELVN
Transaction date
Jun 22, 2026
Public filing date
Jun 24, 2026
Filing lag
Filed 2 days later
ELVN daily price context
Close on/before transaction
$45.96
Jun 22, 2026
First close after public filing
$49.12
Jun 25, 2026
30-day return after filing
+7.8%
Through Jul 24, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 787,024 shares @ $45.38
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000947871-26-000653
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$39.01M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Enliven Therapeutics, Inc. ELVN | Sale | Jun 22, 2026 | $1.13M |
| Enliven Therapeutics, Inc. ELVN | Sale | Jun 22, 2026 | $66.47K |
| Enliven Therapeutics, Inc. ELVN Current | Sale | Jun 22, 2026 | $35.72M |
| Enliven Therapeutics, Inc. ELVN | Sale | Jun 22, 2026 | $2.1M |